Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Why do most modern medical clinics no longer prescribe Sermorelin
To learn more about participating in a clinical trial, contact us
Retatrutide is used in research settings to examine GLP-1 pathway activity in combination with other receptor systems rather than as an isolated single-target model
Retatrutide is characterized as a triple receptor agonist involving three receptor pathways: 01 | GLP-1 - Glucagon-Like Peptide-1 receptors 02 | GIP - Glucose-Dependent Insulinotropic Polypeptide receptors 03 | Glucagon - Glucagon receptor pathways Scientific research involving Retatrutide includes metabolic and endocrinology signaling, receptor interactions, glucose metabolism models and analytical testing
US$ 23.33
US$ 22.55
US$ 23.08
US$ 29.85
US$ 28.14
US$ 21.57
US$ 23.65
US$ 20.52
US$ 23.41
